Carbapenem Antibiotics Versus Other Antibiotics for Complicated Intra-abdominal Infections: a Systematic Review and Patient-Level Meta-analysis of Randomized Controlled Trials (PROSPERO CRD42018108854)

go back to reference Blot S, Antonelli M, Arvaniti K, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med. 2019;45(12):1703-1717. https://doi.org/10.1007/s00134-019-05819-3CrossRefPubMedPubMedCentral Blot S, Antonelli M, Arvaniti K, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med. 2019;45(12):1703-1717. https://​doi.​org/​10.​1007/​s00134-019-05819-3CrossRefPubMedPubMedCentral

go back to reference Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://​doi.​org/​10.​1136/​bmj.​n71

go back to reference Max Heckler, Laura Schlicht, Christoph W. Michalski. Antibiotic treatment after surgery for complicated intraabdominal infections: a systematic review and meta-analysis. PROSPERO 2018 CRD42018108854 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018108854 Max Heckler, Laura Schlicht, Christoph W. Michalski. Antibiotic treatment after surgery for complicated intraabdominal infections: a systematic review and meta-analysis. PROSPERO 2018 CRD42018108854 Available from: https://​www.​crd.​york.​ac.​uk/​prospero/​display_​record.​php?​ID=​CRD42018108854

go back to reference Gonzenbach, H. R., Simmen, H. P., & Amgwerd, R. (1987). Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections. Annals of Surgery, 205(3), 271–275. https://doi.org/10.1097/00000658-198703000-00009 Gonzenbach, H. R., Simmen, H. P., & Amgwerd, R. (1987). Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections. Annals of Surgery, 205(3), 271–275. https://​doi.​org/​10.​1097/​00000658-198703000-00009

go back to reference Brismar, B., Malmborg, A. S., Tunevall, G., Wretlind, B., Bergman, L., Mentzing, L., … Nordlt, C. E. (1992). Treatment of intra-abdominal infections, 36(12), 2766–2773. Brismar, B., Malmborg, A. S., Tunevall, G., Wretlind, B., Bergman, L., Mentzing, L., … Nordlt, C. E. (1992). Treatment of intra-abdominal infections, 36(12), 2766–2773.

go back to reference Kanellakopoulou, K., Giamarellou, H., Papadothomakos, P., Tsipras, H., Chloroyiannis, J., Theakou, R., & Sfikakis, P. (1993). Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery. European Journal of Clinical Microbiology & Infectious Diseases, 12(6), 449–453. https://doi.org/10.1007/BF01967440CrossRef Kanellakopoulou, K., Giamarellou, H., Papadothomakos, P., Tsipras, H., Chloroyiannis, J., Theakou, R., & Sfikakis, P. (1993). Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery. European Journal of Clinical Microbiology & Infectious Diseases, 12(6), 449–453. https://​doi.​org/​10.​1007/​BF01967440CrossRef

go back to reference Angerås, M. H., Darle, N., Hamnström, K., Ekelund, M., Engström, L., Takala, J., … Holme, J. B. (1996). A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections. Scandinavian Journal of Infectious Diseases, 28(5), 513–518. https://doi.org/10.3109/00365549609037950 Angerås, M. H., Darle, N., Hamnström, K., Ekelund, M., Engström, L., Takala, J., … Holme, J. B. (1996). A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections. Scandinavian Journal of Infectious Diseases, 28(5), 513–518. https://​doi.​org/​10.​3109/​0036554960903795​0

go back to reference Kempf, P., Bauernfeind, A., Müller, A., & Blum, J. (1996). Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections. Infection, 24(6), 473–479. https://doi.org/10.1007/BF01713053CrossRefPubMed Kempf, P., Bauernfeind, A., Müller, A., & Blum, J. (1996). Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections. Infection, 24(6), 473–479. https://​doi.​org/​10.​1007/​BF01713053CrossRefPubMed

go back to reference Wilson, S. E. (1997). Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections. Clinical Infectious Diseases, 24(SUPPL. 2), 197–206. https://doi.org/10.1093/clinids/24.supplement_2.s197CrossRef Wilson, S. E. (1997). Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections. Clinical Infectious Diseases, 24(SUPPL. 2), 197–206. https://​doi.​org/​10.​1093/​clinids/​24.​supplement_​2.​s197CrossRef

go back to reference Jaccard, C., Troillet, N., Harbarth, S., Zanetti, G., Aymon, D., Schneider, R., … Comett, A. (1999). Erratum: prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis (Antimicrobial Agents and Chemotherapy (1998) 42:11 (2666–2972)). Antimicrobial Agents and Chemotherapy, 43(3), 726. https://doi.org/10.1128/AAC.43.3.726 Jaccard, C., Troillet, N., Harbarth, S., Zanetti, G., Aymon, D., Schneider, R., … Comett, A. (1999). Erratum: prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis (Antimicrobial Agents and Chemotherapy (1998) 42:11 (2666–2972)). Antimicrobial Agents and Chemotherapy, 43(3), 726. https://​doi.​org/​10.​1128/​AAC.​43.​3.​726

go back to reference Solomkin, J. S., Wilson, S. E., Christou, N. V., Rotstein, O. D., Dellinger, E. P., Bennion, R. S., … Tack, K. (2001). Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Annals of Surgery, 233(1), 79–87. https://doi.org/10.1097/00000658-200101000-00013 Solomkin, J. S., Wilson, S. E., Christou, N. V., Rotstein, O. D., Dellinger, E. P., Bennion, R. S., … Tack, K. (2001). Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Annals of Surgery, 233(1), 79–87. https://​doi.​org/​10.​1097/​00000658-200101000-00013

go back to reference Solomkin, J. S., Yellin, A. E., Rotstein, O. D., Christou, N. V., Dellinger, E. P., Tellado, J. M., … Teppler, H. (2003). Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Annals of Surgery, 237(2), 235–245. https://doi.org/10.1097/01.sla.0000048551.32606.73 Solomkin, J. S., Yellin, A. E., Rotstein, O. D., Christou, N. V., Dellinger, E. P., Tellado, J. M., … Teppler, H. (2003). Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Annals of Surgery, 237(2), 235–245. https://​doi.​org/​10.​1097/​01.​sla.​0000048551.​32606.​73

go back to reference Catena, F., Vallicelli, C., Ansaloni, L., Sartelli, M., Di Saverio, S., Schiavina, R., … Pinna, A. D. (2013). T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam. BMC Gastroenterology, 13(1). https://doi.org/10.1186/1471-230X-13-76 Catena, F., Vallicelli, C., Ansaloni, L., Sartelli, M., Di Saverio, S., Schiavina, R., … Pinna, A. D. (2013). T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam. BMC Gastroenterology, 13(1). https://​doi.​org/​10.​1186/​1471-230X-13-76

go back to reference Lucasti, C., Popescu, I., Ramesh, M. K., Lipka, J., & Sable, C. (2013). Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, phase II trial. Journal of Antimicrobial Chemotherapy, 68(5), 1183–1192. https://doi.org/10.1093/jac/dks523CrossRefPubMed Lucasti, C., Popescu, I., Ramesh, M. K., Lipka, J., & Sable, C. (2013). Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, phase II trial. Journal of Antimicrobial Chemotherapy, 68(5), 1183–1192. https://​doi.​org/​10.​1093/​jac/​dks523CrossRefPubMed

go back to reference Ross JT, Matthay MA, Harris HW. Secondary peritonitis: principles of diagnosis and intervention. BMJ. 2018;361:k1407.https://doi.org/10.1136/bmj.k1407 Ross JT, Matthay MA, Harris HW. Secondary peritonitis: principles of diagnosis and intervention. BMJ. 2018;361:k1407.https://​doi.​org/​10.​1136/​bmj.​k1407

go back to reference Ordoñez CA, Puyana JC. Management of peritonitis in the critically ill patient. Surg Clin North Am. 2006;86(6):1323-1349. https://doi.org/10.1016/j.suc.2006.09.006CrossRefPubMedPubMedCentral Ordoñez CA, Puyana JC. Management of peritonitis in the critically ill patient. Surg Clin North Am. 2006;86(6):1323-1349. https://​doi.​org/​10.​1016/​j.​suc.​2006.​09.​006CrossRefPubMedPubMedCentral

go back to reference Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016 Jul 15;11:33. https://doi.org/10.1186/s13017-016-0089-y. Erratum in: World J Emerg Surg. 2017 Aug 2;12 :35. PMID: 27429642; PMCID: PMC4946132. Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016 Jul 15;11:33. https://​doi.​org/​10.​1186/​s13017-016-0089-y. Erratum in: World J Emerg Surg. 2017 Aug 2;12 :35. PMID: 27429642; PMCID: PMC4946132.

go back to reference Eckmann C, Dryden M, Montravers P, et al. Antimicrobial treatment of “complicated” intra-abdominal infections and the new IDSA guidelines? A commentary and an alternative European approach according to clinical definitions. Eur J Med Res 2011;16:115–26.CrossRefPubMedPubMedCentral Eckmann C, Dryden M, Montravers P, et al. Antimicrobial treatment of “complicated” intra-abdominal infections and the new IDSA guidelines? A commentary and an alternative European approach according to clinical definitions. Eur J Med Res 2011;16:115–26.CrossRefPubMedPubMedCentral

go back to reference Solomkin JS, Mazuski JE, Bradley JS. et al.Diagnosis and management of complicated intra-abdominal infections in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Inf Dis. 2010;50:133–64. https://doi.org/10.1086/649554.CrossRef Solomkin JS, Mazuski JE, Bradley JS. et al.Diagnosis and management of complicated intra-abdominal infections in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Inf Dis. 2010;50:133–64. https://​doi.​org/​10.​1086/​649554.CrossRef

go back to reference Nguyen CP, Dan Do TN, Bruggemann R, Ten Oever J, Kolwijck E, Adang EMM, Wertheim HFL. Clinical cure rate and cost-effectiveness of carbapenem-sparing beta-lactams vs. meropenem for Gram-negative infections: a systematic review, meta-analysis, and cost-effectiveness analysis. Int J Antimicrob Agents. 2019 Dec;54(6):790–797. https://doi.org/10.1016/j.ijantimicag.2019.07.003. Epub 2019 Jul 5. PMID: 31284041. Nguyen CP, Dan Do TN, Bruggemann R, Ten Oever J, Kolwijck E, Adang EMM, Wertheim HFL. Clinical cure rate and cost-effectiveness of carbapenem-sparing beta-lactams vs. meropenem for Gram-negative infections: a systematic review, meta-analysis, and cost-effectiveness analysis. Int J Antimicrob Agents. 2019 Dec;54(6):790–797. https://​doi.​org/​10.​1016/​j.​ijantimicag.​2019.​07.​003. Epub 2019 Jul 5. PMID: 31284041.

go back to reference Chen L, Liang X, Jiang J, Li X, Li Y. Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: a Bayesian network meta-analysis of randomized clinical trials. Medicine (Baltimore). 2019;98(40):e17436. https://doi.org/10.1097/MD.0000000000017436 Chen L, Liang X, Jiang J, Li X, Li Y. Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: a Bayesian network meta-analysis of randomized clinical trials. Medicine (Baltimore). 2019;98(40):e17436. https://​doi.​org/​10.​1097/​MD.​0000000000017436​

go back to reference Li Y, Chen L, Jiang J, Li X, Huang T, Liang X. Carbapenems vs β-lactam monotherapy or combination therapy for the treatment of complicated intra-abdominal infections: systematic review and meta-analysis of randomized controlled trials. Open Forum Infect Dis. 2019;6(10):ofz394. Published 2019 Sep 9. https://doi.org/10.1093/ofid/ofz394 Li Y, Chen L, Jiang J, Li X, Huang T, Liang X. Carbapenems vs β-lactam monotherapy or combination therapy for the treatment of complicated intra-abdominal infections: systematic review and meta-analysis of randomized controlled trials. Open Forum Infect Dis. 2019;6(10):ofz394. Published 2019 Sep 9. https://​doi.​org/​10.​1093/​ofid/​ofz394

go back to reference Zhanel, G.G., Wiebe, R., Dilay, L. et al. Comparative review of the carbapenems. Drugs 67, 1027–1052 (2007). https://doi.org/10.2165/00003495-200767070-00006CrossRefPubMed Zhanel, G.G., Wiebe, R., Dilay, L. et al. Comparative review of the carbapenems. Drugs 67, 1027–1052 (2007). https://​doi.​org/​10.​2165/​00003495-200767070-00006CrossRefPubMed

go back to reference Kuehn, B.M. “Nightmare” bacteria on the rise in US hospitals, long-term care facilities. JAMA 2013, 309, 1573–1574.CrossRefPubMed Kuehn, B.M. “Nightmare” bacteria on the rise in US hospitals, long-term care facilities. JAMA 2013, 309, 1573–1574.CrossRefPubMed

go back to reference Kaye, K. S., Marchaim, D., Thamlikitkul, V., Carmeli, Y., Chiu, C.-H., Daikos, G., Dhar, S., Durante-Mangoni, E., Gikas, A., Kotanidou, A., Paul, M., Roilides, E., Rybak, M., Samarkos, M., Sims, M., Tancheva, D., Tsiodras, S., Kett, D., Patel, G., … Pogue, J. M. (2023). Colistin monotherapy versus combination therapy for carbapenem-resistant organisms. NEJM Evidence, 2(1). https://doi.org/10.1056/evidoa2200131 Kaye, K. S., Marchaim, D., Thamlikitkul, V., Carmeli, Y., Chiu, C.-H., Daikos, G., Dhar, S., Durante-Mangoni, E., Gikas, A., Kotanidou, A., Paul, M., Roilides, E., Rybak, M., Samarkos, M., Sims, M., Tancheva, D., Tsiodras, S., Kett, D., Patel, G., … Pogue, J. M. (2023). Colistin monotherapy versus combination therapy for carbapenem-resistant organisms. NEJM Evidence, 2(1). https://​doi.​org/​10.​1056/​evidoa2200131

go back to reference Codjoe, F.S.; Donkor, E.S. Carbapenem resistance: a review. Med. Sci. 2018, 6, 1. https://doi.org/10.3390/medsci6010001CrossRef Codjoe, F.S.; Donkor, E.S. Carbapenem resistance: a review. Med. Sci. 2018, 6, 1. https://​doi.​org/​10.​3390/​medsci6010001CrossRef